Samuel Krebs graduated from ETH Zurich in 2024 with a Master’s degree in Pharmacy and the federal diploma as a pharmacist. He then worked in a community pharmacy while completing his FPH postgraduate training in community pharmacy, first full-time and later part-time. In March 2026, he joined the Pharmaceutical Care Research Group in Basel as a PhD student. His research focuses on AI-supported medication analysis, particularly the Medication Appropriateness Index (MAI), with the aim of improving medication safety and optimizing pharmacotherapy.